STOCK TITAN

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Medicine Man Technologies, Inc., operating as Schwazze, will hold a conference call on May 15, 2024, to discuss its first-quarter financial and operational results. The call will be followed by a Q&A session, and interested parties can submit questions in advance.

Medicine Man Technologies, Inc., che opera come Schwazze, terrà una conferenza telefonica il 15 maggio 2024 per discutere i risultati finanziari e operativi del primo trimestre. La chiamata sarà seguita da una sessione di domande e risposte, e le parti interessate possono inviare domande in anticipo.
Medicine Man Technologies, Inc., operando como Schwazze, realizará una llamada de conferencia el 15 de mayo de 2024 para discutir sus resultados financieros y operativos del primer trimestre. La llamada será seguida por una sesión de preguntas y respuestas, y las partes interesadas pueden enviar preguntas con anticipación.
Medicine Man Technologies, Inc., Schwazze로 운영되며, 2024년 5월 15일에 1분기 재무 및 운영 결과에 대해 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다. 이 통화는 질의응답 세션을 포함하며, 관심 있는 당사자는 사전에 질문을 제출할 수 있습니다.
Medicine Man Technologies, Inc., opérant sous le nom de Schwazze, tiendra une conférence téléphonique le 15 mai 2024 pour discuter de ses résultats financiers et opérationnels du premier trimestre. L'appel sera suivi d'une session de questions-réponses, et les parties intéressées peuvent soumettre leurs questions à l'avance.
Medicine Man Technologies, Inc., unter dem Namen Schwazze tätig, wird am 15. Mai 2024 eine Telefonkonferenz abhalten, um über die finanziellen und betrieblichen Ergebnisse des ersten Quartals zu sprechen. Dem Anruf wird eine Fragerunde folgen, und interessierte Parteien können vorab Fragen einreichen.
Positive
  • None.
Negative
  • None.

DENVER, April 29, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024. The Company's results will be reported in a press release prior to the call.

The Schwazze management team will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing ir@schwazze.com.

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company's website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company's leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze's former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit http://www.schwazze.com/.

Investor Relations Contact

Sean Mansouri, CFA or Aaron D'Souza
Elevate IR
(720) 330-2829
ir@schwazze.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/schwazze-sets-first-quarter-2024-conference-call-for-may-15-2024-at-500-pm-et-302130408.html

SOURCE Schwazze

FAQ

When is Schwazze's first quarter 2024 conference call?

Schwazze's first quarter 2024 conference call is scheduled for May 15, 2024, at 5:00 p.m. Eastern time.

How can interested parties submit questions in advance?

Interested parties can submit questions to the Company prior to the call by emailing ir@schwazze.com.

Where can the Schwazze first quarter 2024 financial results be found?

The Company's first-quarter results will be reported in a press release prior to the call and will also be available on the investor relations section of the Company's website at https://ir.schwazze.com.

Medicine Man Technologies, Inc.

OTC:SHWZ

SHWZ Rankings

SHWZ Latest News

SHWZ Stock Data

50.39M
60.76M
21.24%
0.4%
Administrative Management and General Management Consulting Services
Professional, Scientific, and Technical Services
Link
United States of America
Denver

About SHWZ

medicine man technologies, (symbol: mdcl), offers full service cannabis consulting and licensing of our state-of-the-art, turnkey cultivation and dispensary operating solutions. we represent and license the cultivation and dispensary ip of medicine man, a prominent tier iii colorado operator. we help clients navigate state applications, facility design, business and financial planning, as well as facilitate the adoption of operating procedures and training materials to teach your organization how to effectively operate a commercial cultivation and retail dispensary. we provide the experience and expertise to clients who have the resources necessary to enter the competitive medical and adult use cannabis marketplace, helping to mitigate the costly mistakes that many new companies will experience.